DNA Methylation Detection via Enzymatic Ligation and Restriction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting DNA methylation, such as methylation-sensitive restriction endonuclease assays and sodium bisulfite-based approaches, face challenges like false positives, false negatives, and insensitivity, especially when detecting low levels of methylated DNA in the presence of a majority of unmethylated DNA, which is crucial for early cancer detection.

Innovation Solution

A method involving methylation-sensitive restriction enzyme digestion, oligonucleotide probe sets, and ligation reactions to specifically identify target nucleic acid molecules with methylated residues, using 5' nuclease activity and thermostable ligases to form ligation products that are then distinguished based on methylation status.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If methylation-sensitive restriction endonuclease assays are used to detect methylated DNA, then the method can identify methylated sequences, but false positives occur due to incomplete digestion of unmethylated DNA

Engineering Contradiction:
Improvedetection accuracyVSAvoidfalse positive rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent combines restriction enzyme digestion with oligonucleotide ligation reactions to create a multi-step detection system. The restriction enzyme cleaves unmethylated DNA at recognition sites, and subsequent ligation of oligonucleotide probes to the cleaved fragments provides confirmatory evidence of methylation status, reducing false positives from incomplete digestion

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent performs restriction enzyme digestion as a preliminary step before ligation and amplification. By pre-cleaving unmethylated DNA fragments, the method prepares the sample in advance to enable selective ligation of probes only to methylated templates, improving detection accuracy

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If sodium bisulfite conversion is used to detect DNA methylation, then methylation status can be determined through sequence analysis, but the method produces false negatives and has reduced sensitivity

Engineering Contradiction:
Improvemethylation detection accuracyVSAvoidfalse negative rate
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The patent uses oligonucleotide probes as intermediaries that hybridize to methylated DNA sequences after restriction digestion. These probes serve as mediators between the methylated template and the detection system, providing specific and sensitive detection without the artifacts of bisulfite conversion

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the chemical conversion mechanism of bisulfite treatment with an enzymatic approach using restriction enzymes and ligases. This substitution maintains detection capability while avoiding the DNA degradation and false negatives associated with harsh chemical conversion

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Ease of operation

If single marker detection is used for early cancer detection, then the method is simple to implement, but false-positive and false-negative results are unacceptably high

Engineering Contradiction:
Improvedetection simplicityVSAvoiddiagnostic accuracy
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent divides the detection system into multiple independent components: multiple oligonucleotide probes targeting different methylation markers, each capable of being detected separately. This segmentation allows simultaneous monitoring of multiple cancer-related genes (e.g., CDKN2A, RASSF1A, APC) while maintaining operational simplicity through a unified assay format

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates a universal detection platform using common oligonucleotide probes and restriction enzymes that can detect multiple different methylation markers. The same basic assay components serve multiple functions across different cancer detection applications, maintaining simplicity while improving diagnostic reliability through multiplexing

Inventive Principle:
Principle #6Universality (Multi-functionality)

4Measurement precision

If detection methods are designed to detect very low levels of methylated DNA in predominantly unmethylated samples, then early cancer detection sensitivity improves, but the complexity of the detection system increases

Engineering Contradiction:
Improvedetection sensitivityVSAvoidassay complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent performs restriction enzyme digestion as a preliminary enrichment step that selectively cleaves unmethylated DNA fragments before the ligation and amplification steps. This pre-processing action removes the overwhelming background of unmethylated DNA, enabling sensitive detection of low-abundance methylated targets without requiring overly complex assay designs

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses oligonucleotide probes that copy or replicate the methylation-specific sequence information through ligation and subsequent amplification. This copying mechanism amplifies the signal from rare methylated molecules, enhancing detection sensitivity while using standard, relatively simple molecular biology techniques

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enhances sensitivity and specificity for detecting low-abundance methylated DNA, reducing false positives and negatives, and allows for accurate identification of methylation status even in samples with predominantly unmethylated DNA.

Implementation Method 1

The sample is subjected to a methylation sensitive restriction enzyme digest to cleave target nucleic acid molecules in the sample having non-methylated residues within the at least one methylation sensitive restriction enzyme sequence

Methodology Applied
Scientific EffectRestriction enzyme digestion: Enzyme

Implementation Method 2

contacting the sample and the one or more oligonucleotide probe sets under conditions effective for first and second oligonucleotide probes of a probe set to hybridize at adjacent positions in a base specific manner to their corresponding target nucleic acid molecule

Methodology Applied
Scientific EffectHybridization:

Implementation Method 3

The overlapping identical nucleotide of the second oligonucleotide probe is cleaved with an enzyme having 5' nuclease activity, thereby liberating a 5' phosphate on the second oligonucleotide probe

Methodology Applied
Scientific EffectNuclease activity: Enzyme

Implementation Method 4

The first and second oligonucleotide probes of the one or more oligonucleotide probe sets are ligated together at the junction to form a ligation product hybridized to its complementary target nucleic acid molecule

Methodology Applied
Scientific EffectLigation: Enzyme

Data Source

PatentEP3126523B1Detection of DNA methylation using combined nuclease ligation reactions
Publication Date: 2020.02.19 CORNELL UNIVERSITY
  • EP3126523B1 patent drawingFigure 1(a)~1(d)
  • EP3126523B1 patent drawingFigure 2A~2I
  • EP3126523B1 patent drawingFigure 3A~3I

AI summary

The present invention is directed to methods for identifying the presence of one or more methylated or unmethylated target nucleotide sequences in a sample that involve coupled methylation sensitive restriction enzyme digestion-ligation and/or extension processes. In some embodiments, the ligation and primary extension products formed in the reaction processes of the present invention are subsequently amplified using a polymerase chain reaction. The ligation products or primary extension products are detected, and the presence of one or more methylated or unmethylated target nucleotide sequences in the sample is identified based on the detection.